Search Results - "Burt Nabors, L."
-
1
Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
Published in Journal of clinical oncology (10-09-2013)“…A randomized, phase III, placebo-controlled, partially blinded clinical trial (REGAL [Recent in in Glioblastoma Alone and With Lomustine]) was conducted to…”
Get full text
Journal Article -
2
MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials
Published in Clinical cancer research (15-03-2019)“…The methylation status of the O -methylguanine DNA methyltransferase ( ) gene promoter is predictive for benefit from temozolomide in glioblastoma (GBM). A…”
Get full text
Journal Article -
3
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma
Published in Journal of clinical oncology (01-03-2016)“…Symptomatic epilepsy is a common complication of glioblastoma and requires pharmacotherapy. Several uncontrolled retrospective case series and a post hoc…”
Get full text
Journal Article -
4
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
Published in Neuro-oncology (Charlottesville, Va.) (01-08-2017)“…Radiation with concurrent and adjuvant (6 cycles) temozolomide (TMZ) is the established standard of postsurgical care for newly diagnosed glioblastoma (GBM)…”
Get full text
Journal Article -
5
RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disorders
Published in Glia (01-03-2023)“…A major hallmark of neuroinflammation is the activation of microglia and astrocytes with the induction of inflammatory mediators such as IL‐1β, TNF‐α, iNOS,…”
Get full text
Journal Article -
6
Implementation and utilization of the molecular tumor board to guide precision medicine
Published in Oncotarget (22-08-2017)“…With rapid advances in genomic medicine, the complexity of delivering precision medicine to oncology patients across a university health system demanded the…”
Get full text
Journal Article -
7
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma
Published in Journal of neuro-oncology (01-10-2023)“…Introduction Hypoxia inducible factor 2-alpha (HIF2α) mediates cellular responses to hypoxia and is over-expressed in glioblastoma (GBM). PT2385 is an oral…”
Get full text
Journal Article -
8
Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?
Published in Journal of neuro-oncology (01-05-2018)“…Glioblastomas are malignant brain tumors with poor prognosis. Lately, data from clinical studies assessing the role of co-medications in different cancer types…”
Get full text
Journal Article -
9
Phase I and Correlative Biology Study of Cilengitide in Patients With Recurrent Malignant Glioma
Published in Journal of clinical oncology (01-05-2007)“…This multi-institutional phase I trial was designed to determine the maximum-tolerated dose (MTD) of cilengitide (EMD 121974) and to evaluate the use of…”
Get full text
Journal Article -
10
Letter: When Less is More: Dexamethasone Dosing for Brain Tumors
Published in Neurosurgery (01-09-2019)Get full text
Journal Article -
11
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
Published in Journal of clinical oncology (01-12-2008)“…Cilengitide, an inhibitor of alphavbeta3 and alphavbeta5 integrin receptors, demonstrated minimal toxicity and durable activity across a wide range of doses…”
Get full text
Journal Article -
12
Mapping uncharted territory: a gene expression signature for precision glioblastoma therapeutics
Published in Neuro-oncology (Charlottesville, Va.) (18-12-2020)Get full text
Journal Article -
13
“It's Not Just the Seizures”: Brain Tumor Caregivers’ Experiences and Educational Needs in Out-of-Hospital Seizure Management
Published in Journal of palliative care (01-07-2023)“…Objective: Family caregivers (FCGs) of persons with primary brain tumors (PBTs) report high levels of distress related to concerns about out-of-hospital…”
Get full text
Journal Article -
14
-
15
The RNA-binding protein HuR promotes glioma growth and treatment resistance
Published in Molecular cancer research (01-05-2011)“…Posttranscriptional regulation is a critical control point for the expression of genes that promote or retard tumor growth. We previously found that the…”
Get full text
Journal Article -
16
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma
Published in Clinical cancer research (01-01-2019)“…Iniparib is a purported prodrug causing cell death through intracellular conversion to nitro radical ions. We assessed the efficacy and safety of iniparib with…”
Get full text
Journal Article -
17
Mitochondrial DNA sequence variation and risk of meningioma
Published in Journal of neuro-oncology (01-12-2021)“…Background Risk factors for meningioma include female gender, African American race, high body mass index (BMI), and exposure to ionizing radiation. Although…”
Get full text
Journal Article -
18
Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics
Published in International journal of cancer (01-02-2020)“…Glioma incidence is highest in non‐Hispanic Whites, and to date, glioma genome‐wide association studies (GWAS) to date have only included European ancestry…”
Get full text
Journal Article -
19
Mitochondrial DNA sequence variation and risk of glioma
Published in Mitochondrion (01-03-2022)“…•The mitochondrial genome (mtDNA) is polymorphic in human populations.•Inherited variants in mtDNA may play a role in cancer risk and progression.•Array-based…”
Get full text
Journal Article -
20
Phase I Single-Dose Study of Intracavitary-Administered Iodine-131-TM-601 in Adults With Recurrent High-Grade Glioma
Published in Journal of clinical oncology (01-08-2006)“…TM-601 binds to malignant brain tumor cells with high affinity and does not seem to bind to normal brain tissue. Preclinical studies suggest that iodine-131…”
Get full text
Journal Article